On August 22, Rekha Jhunjhunwala bought 4.5 million shares of Fortis at Rs 134.65 per share on NSE
Rekha Jhunjhunwala, wife of veteran investor Rakesh Jhunjhunwala, on Tuesday purchased 45 lakh shares of Fortis Healthcare at Rs 134.6 apiece totalling Rs 61 crore through an open market transaction, data put up on National Stock Exchange of India showed.The identity of the seller was not known. Shares of the company fell 12 per cent in early morning trade to Rs 125.5 before recovering to close at Rs 144.4 on the NSE, up 0.48 per cent from the previous day's close.In February 2015, Rakesh Junjhunwala had bought 34.8 lakh shares of Fortis Healthcare at Rs 119.35 per share, for about Rs 41 crore via an open market deal.On August 14, Fortis Healthcare had informed the stock exchanges that Fortis Healthcare Holdings, the promoter of the company, sold 5.46 million, or 1.05 per cent, equity shares on August 10, through an off-market transaction. Earlier, on July 18, Fortis Healthcare Holdings had sold 13.5 million or 2.6 per cent stake of Fortis Healthcare for Rs 203 crore through open ...
Rekha Jhunjhunwala acquires shares worth Rs 61 crore
A combined 19.15 million equity shares changed hands on NSE and BSE till 10:20 am.
Steady growth and value unlocking potential are keeping analysts positive on the company
RBI had put Fortis Healthcare under the ban list last month with respect to foreign investment
Fortis Healthcare earlier got shareholders' nod to raise up to Rs 5,000 crore
The stock slipped 15% to Rs 168 on NSE on back of heavy volumes.
Fortis sources says deal is still on
The Malaysian healthcare major runs chain of hospitals in Asia, and Central and Eastern Europe
The shares of Fortis Healthcare closed at Rs 197.80 per scrip on BSE
Matter pertains to single-use devices that are used for angioplasty to remove blockages in arteries
Fortis Healthcare stock closed 5.25 per cent up at Rs 195.60 on BSE
The stock hit a record high of Rs 205, outperformed the market by gaining 18% in past one month.
Beyond the near-term impact of demonetisation, margin expansion in both hospitals and diagnostic businesses will drive earnings
The hospitals, in Rajasthan, will be operational by March 2017
The move comes after company demerges with SRL diagnostics
The stock surged 11% to Rs 188 on the BSE in early morning trade.
Demerger to unlock value of both the businesses, says senior management
As part of the process, Fortis Malar will sell its hospital business to Fortis Healthcare by way of a slump sale